Drugs / Cycophosphamide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06252870 | Jul 2024 → Oct 2027 expected | graft versus host disease, hematopoietic and lymphoid cell neoplasm | Nantes University Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cycophosphamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06252870 ↗ |